Signal active
Bio
Mark Bakken is the Founder and Managing Director of HealthX Ventures. He is also a General Partner at Cultivation Capital. He previously worked at Nordic as a Co-Founder and CEO. Mark Bakken attended the University of Wisconsin-Madison.
Location
Madison, Wisconsin, United States, North America
Social
Primary Organization
2015
39
19
4
1-10
Information Technology, Developer APIs, Health Care, Pharmaceutical, mHealth
Jobs history
5
RxLightning
Board of director
Invalid date - Current
Recovery.com (formerly RehabPath)
Board Member
2022 - Current
Wellbe
Board Member
2021 - Current
Cultivation Capital
General Partner
Invalid date - Current
Creative Destruction Lab (CDL)
Associate
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Mark Bakken is the Founder, Managing Director at HealthX Ventures, based in United States, North America. With a background in Information Technology, Mark Bakken has a rich history of leadership and innovation. Mark Bakken studied BS Computer Science @ University of Wisconsin-Madison. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
6
2
Personal investment
6
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Nov 26, 2014 | Redox | Seed Round - Redox | 470.0K |
Mar 18, 2015 | healthfinch | Seed Round - healthfinch | 2.4M |
Jun 15, 2016 | One Solstice | Seed Round - One Solstice | 450.0K |
Nov 24, 2021 | Nurse Disrupted | Seed Round - Nurse Disrupted | 700.0K |
Partner investment
6
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Feb 03, 2022 | - | Seed Round - Ideawake | HealthX Ventures | 1.0M |
Mar 03, 2022 | CancerIQ | Series B - CancerIQ | HealthX Ventures | 14.0M |
Jun 06, 2023 | RxLightning | Series A - RxLightning | HealthX Ventures | 17.5M |
Aug 12, 2024 | Amulet | Series A - Amulet | HealthX Ventures | 5.8M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.